ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,246Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 244

$1.62M Total Retail Price of All Prescriptions

Rank: 2 out of 244

532 Patients Receiving at Least One Drug in Part D
19%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 532 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 1,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$144 was the average price of a prescription from this provider, compared to $141 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
CITALOPRAM HBR 669 245 1 6
RISPERIDONE 658 95 2 2
QUETIAPINE FUMARATE 624 100 3 3
BUPROPION XL 561 78 4 11
TRAZODONE HCL 538 108 5 1
OLANZAPINE 463 113 6 8
ABILIFY 416 58 7 5
FLUOXETINE HCL 400 61 8 13
CYMBALTA 395 23 9 10
BENZTROPINE MESYLATE 371 18 R 10 17
LAMOTRIGINE 360 41 11 12
VENLAFAXINE HCL ER 350 52 12 9
SERTRALINE HCL 349 58 13 7
CLOZAPINE 344 11 14 4
MIRTAZAPINE 327 120 15 14
DIVALPROEX SODIUM 270 30 16 25
ZIPRASIDONE HCL 243 0 17 26
ESCITALOPRAM OXALATE 240 25 18 20
PAROXETINE HCL 229 33 19 23
ZOLPIDEM TARTRATE 229 0 19 15
SEROQUEL 218 40 21 19
TOPIRAMATE 165 0 22 27
GABAPENTIN 147 12 23 21
LITHIUM CARBONATE 141 12 24 22
DIVALPROEX SODIUM ER 132 12 25 16
OXCARBAZEPINE 124 0 26 33
RISPERDAL CONSTA 114 41 27 28
ZALEPLON 112 11 28 77
AMITRIPTYLINE HCL 101 19 R 29 50
BUSPIRONE HCL 89 26 30 18
HALOPERIDOL 88 12 31 29
HYDROXYZINE PAMOATE 85 0 R 32 32
CARBAMAZEPINE 80 14 33 45
ZYPREXA 71 0 34 53
DONEPEZIL HCL 68 57 35 35
AMPHETAMINE SALT COMBO 60 0 S2 36 30
INVEGA SUSTENNA 57 0 37 46
LATUDA 54 0 38 44
PRAZOSIN HCL 53 0 39 43
SEROQUEL XR 51 15 40 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.